Pixium Vision (PXMVF) News Today C$1.50 0.00 (0.00%) (As of 12/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period 🧬 This device restores vision to blind people 👁️November 21, 2024 | msn.comPixium Vision SA (PXMVF)October 29, 2024 | ca.finance.yahoo.comScience Corporation acquires retinal implant from Pixium VisionApril 26, 2024 | msn.comWhen Is Apple Vision Pro Coming Out in the UK and Elsewhere?March 27, 2024 | macrumors.comPixium Vision announces the rejection of the sale plan (plan de cession) by the Court and the conversion of the receivership proceedings into liquidation proceedingsFebruary 2, 2024 | finance.yahoo.comPostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings to January 31, 2024January 17, 2024 | finance.yahoo.comPostponement of the decision on the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedingsJanuary 17, 2024 | finance.yahoo.comDecision concerning the adoption of a sale plan (plan de cession) and the opening of judicial liquidation proceedings scheduled for January 16, 2024December 18, 2023 | finance.yahoo.comCommercial Court hearing to examine the takeover offer scheduled for December 18, 2023December 4, 2023 | finance.yahoo.comUpdate on the receivership proceedings: submission of a takeover offer to the court-appointed administratorsNovember 20, 2023 | finance.yahoo.comPixium Vision announces the 48-Month Trial Results in Severe Atrophic AMDNovember 14, 2023 | finance.yahoo.comPixium Vision announces the conversion of the safeguard proceedings into receivershipNovember 13, 2023 | finance.yahoo.comPixium Vision SA Ordinary SharesNovember 4, 2023 | morningstar.comPixium Vision SA GAAP EPS of -€0.07, revenue of €0.9MOctober 26, 2023 | msn.comPixium Vision announces its financial results for H1 2023 and provides updateOctober 26, 2023 | finance.yahoo.comPixium Vision announces the launch of a process to find buyersOctober 18, 2023 | benzinga.comPixium Vision announces the opening of safeguard proceedingsOctober 9, 2023 | benzinga.comPixium Vision announces the completion of the reverse stock split of its shares on the basis of 1 new share for 50 existing shares and the start of trading of the shares resulting after the completion of the reverse split as of Sep 21, 2023September 20, 2023 | finance.yahoo.comPixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing sharesJuly 28, 2023 | finance.yahoo.comPixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facilityJuly 11, 2023 | finance.yahoo.comResults of the Annual General Shareholder Meeting as of June 13, 2023June 15, 2023 | finance.yahoo.comPixium Vision announces receipt of € 1.8 million from the French Government as Research Tax CreditJune 12, 2023 | finance.yahoo.comBefore 'car chase,' Duchess Meghan spoke about fighting for equity at Women of Vision galaJune 9, 2023 | usatoday.comPixium Vision announces receipt of € 1.8 million from the French Government as Research Tax CreditJune 8, 2023 | finance.yahoo.comAnnual Meeting of Shareholders June 13, 2023 / Availability of preparatory documentsMay 24, 2023 | finance.yahoo.comPixium Vision S.A.May 23, 2023 | wsj.comPixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023May 10, 2023 | finance.yahoo.comPixium Vision announces the availability of its annual report for the financial year 2022April 25, 2023 | finance.yahoo.comPixium Vision announces its consolidated financial statements for the financial year 2022 and the consolidated cash balance for March 31, 2023April 21, 2023 | finance.yahoo.comCommunication following the announcement of FDA Breakthrough Device Designation for the Prima System in Dry AMDApril 3, 2023 | finance.yahoo.comPixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMDMarch 31, 2023 | finance.yahoo.comReduction of share capital due to losses by reduction of nominal value: number of shares unchangedMarch 17, 2023 | finance.yahoo.comResults of Extraordinary Shareholders Meeting held on March 8, 2023March 10, 2023 | finance.yahoo.comExtraordinary Shareholder Meeting of March 8, 2023: Notice of publication of the preparatory documentsFebruary 28, 2023 | finance.yahoo.comSecond convening of the Extraordinary Shareholder Meeting on March 8, 2023February 16, 2023 | finance.yahoo.comPixium Vision announces its cash position at 31 December 2022 and provides an update on its activitiesFebruary 14, 2023 | finance.yahoo.comPixium Vision announces termination of convertible note financing agreement with US-based healthcare investor ESGOFebruary 13, 2023 | finance.yahoo.comExtraordinary General Meeting of February 15, 2023: Notice of publication of the preparatory documentsJanuary 27, 2023 | finance.yahoo.comPixium Vision convenes an Extraordinary General Meeting of Shareholders on February 15, 2023January 20, 2023 | finance.yahoo.comPixium Vision announces peer-reviewed publications demonstrating the potential of the Next Generation PRIMA implant to restore vision at five times higher resolution than current implantJanuary 12, 2023 | finance.yahoo.comPixium Vision announces completion of implantations in the European pivotal trial PRIMAvera and confirms target read-out around the end of 2023 and regulatory submission in Europe in H1 2024December 15, 2022 | finance.yahoo.comPixium Vision announces participation in investor conferences in November and December 2022November 15, 2022 | finance.yahoo.comPixium Vision SA (ALPIX)November 6, 2022 | investing.comPixium Vision announces its cash position at 30 September 2022 and provides an update on its activitiesOctober 21, 2022 | finance.yahoo.comPixium Vision announces the publication of peer-reviewed clinical data of the Prima System in Dry AMD in the Journal of Neural EngineeringOctober 11, 2022 | finance.yahoo.comPixium Vision announces participation in investor conferences and events in October 2022October 4, 2022 | finance.yahoo.comPixium Vision to host open house event for investors on October 13th 2022 from 5 pmSeptember 21, 2022 | finance.yahoo.comPixium Vision announces reaching its enrollment target in the European pivotal trial PRIMAvera and implantations planned to be completed by end 2022September 19, 2022 | finance.yahoo.comPixium Vision announces implantation of first patient in Italy in Prima System European pivotal trial PRIMAveraSeptember 13, 2022 | finance.yahoo.comPixium Vision announces participation in upcoming investor conferences in September 2022September 6, 2022 | finance.yahoo.com Get Pixium Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol PXMVF Media Mentions By Week PXMVF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PXMVF News Sentiment▼0.000.60▲Average Medical News Sentiment PXMVF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PXMVF Articles This Week▼00▲PXMVF Articles Average Week Get Pixium Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for PXMVF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ansell News Ansell News Carl Zeiss Meditec News Coloplast A/S News ConvaTec Group News Fisher & Paykel Healthcare News Gerresheimer News InnerScope Hearing Technologies News Innovative Eyewear News Nanosonics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:PXMVF) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredRare "crisis signal" triggers for third time in U.S. marketA rare pattern has just repeated for the third time in U.S. history. The last two times this happened, the...Stansberry Research | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pixium Vision SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Pixium Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
